Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(11%)
Results Posted
14%(1 trials)

Phase Distribution

Ph phase_2
3
33%
Ph phase_4
1
11%
Ph not_applicable
5
56%

Phase Distribution

0

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
3(33.3%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
5(55.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(7)

Detailed Status

Completed7
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (33.3%)
Phase 41 (11.1%)
N/A5 (55.6%)

Trials by Status

completed778%
recruiting111%
not_yet_recruiting111%

Recent Activity

1 active trials
Showing 5 of 9
recruitingphase_2

Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

NCT06975111
not_yet_recruitingnot_applicable

Implementation and Evaluation of Bump2Baby and Me+ Programme for Gestational Diabetes Mellitus in Routine Maternity Care Setting.

NCT07189221
completednot_applicable

(Pakistan Diabetes Prevention Program PDPP)

NCT01530165
completedphase_2

Effect of the SCL16A11 Risk Haplotype on Treatments to Prevent Type 2 Diabetes

NCT05990205
completedphase_4

Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD Patients

NCT05474560
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT06975111Phase 2

Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

Recruiting
NCT07189221Not Applicable

Implementation and Evaluation of Bump2Baby and Me+ Programme for Gestational Diabetes Mellitus in Routine Maternity Care Setting.

Not Yet Recruiting
NCT01530165Not Applicable

(Pakistan Diabetes Prevention Program PDPP)

Completed
NCT05990205Phase 2

Effect of the SCL16A11 Risk Haplotype on Treatments to Prevent Type 2 Diabetes

Completed
NCT05474560Phase 4

Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD Patients

Completed
NCT03305939Not Applicable

Lifestyle Intervention IN Gestational Diabetes (LIVING)

Completed
NCT01221363Not Applicable

Reduction of Sitting Time: Sedentarism Intervention Trial

Completed
NCT01906086Not Applicable

Effects of Legume Consumption on Adiponectin and Inflammatory Markers Among Adults

Completed
NCT00633282Phase 2

Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease

Completed

All 9 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
9